Skandinaviska Enskilda Banken (SEB)
IMVT icon

Skandinaviska Enskilda Banken (SEB)’s Immunovant IMVT Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-35,316
Closed -$603K – 864
2025
Q1 		$603K Hold
35,316
– – ﹤0.01% 675
2024
Q4 		$843K Sell
35,316
-53,152
-60% -$1.51M ﹤0.01% 672
2024
Q3 		$2.52M Sell
88,468
-188,554
-68% -$5.56M 0.01% 543
2024
Q2 		$7.3M Hold
277,022
– – 0.04% 311
2024
Q1 		$8.93M Sell
277,022
-404,913
-59% -$14.8M 0.04% 295
2023
Q4 		$28.7M Hold
681,935
– – 0.17% 122
2023
Q3 		$26.2M Buy
681,935
+160,851
+31% +$3.64M 0.17% 114
2023
Q2 		$9.88M Buy
+521,084
New +$9.72M 0.06% 265

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AGM
Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s IMVT Position: Q2 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Immunovant (IMVT) in Q2 2025, closing a stake of 35,316 shares — an estimated $603K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in IMVT in Q2 2023 and held it in 8 quarters. The position peaked at $28.7M in Q4 2023. 168 funds tracked by Wall St. Rank hold IMVT as of Q2 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Immunovant position as of Q2 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 35,316 Immunovant shares in Q2 2025, an estimated $603K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Immunovant in Q2 2023 and held it in 8 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Immunovant position peaked at $28.7M in Q4 2023.
  • 168 funds tracked by Wall St. Rank held Immunovant as of Q2 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2025, filed 13 Aug 2025.